Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics von Vasiliauskas, E A, Kam, L Y, Karp, L C, Gaiennie, J, Yang, H, Targan, S R

Volltext

Split-dose administration of thiopurine drugs: a novel and effective strategy for managing preferential 6-MMP metabolism von Shih, D. Q., Nguyen, M., Zheng, L., Ibanez, P., Mei, L., Kwan, L. Y., Bradford, K., Ting, C., Targan, S. R., Vasiliauskas, E. A.

Volltext

Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn’s disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral densi... von Abreu, M T, Kantorovich, V, Vasiliauskas, E A, Gruntmanis, U, Matuk, R, Daigle, K, Chen, S, Zehnder, D, Lin, Y-C, Yang, H, Hewison, M, Adams, J S

Volltext

High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-a... von Fleshner, P R, Vasiliauskas, E A, Kam, L Y, Fleshner, N E, Gaiennie, J, Abreu-Martin, M T, Targan, S R

Volltext

Antibodies to CBir1 Flagellin Define a Unique Response That Is Associated Independently With Complicated Crohn’s Disease von Targan, Stephan R., Landers, Carol J., Yang, Huiying, Lodes, Michael J., Cong, Yingzi, Papadakis, Konstantinos A., Vasiliauskas, Eric, Elson, Charles O., Hershberg, Robert M.

Volltext

An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease von Vasiliauskas, Eric A., Kam, Lori Y., Abreu-Martin, Maria T., Hassard, Philip V., Papadakis, Kostas A., Yang, Huiying, Zeldis, Jerome B., Targan, Stephan R.

Volltext

Long‐term outcomes of thalidomide in refractory Crohn's disease von Gerich, M. E., Yoon, J. L., Targan, S. R., Ippoliti, A. F., Vasiliauskas, E. A.

Volltext

Editorial: is thalidomide a good option for patients with refractory Crohn's disease? Authors’ reply von Gerich, M., Yoon, J., Vasiliauskas, E.

Volltext

Efficacy and safety of retreatment with anti–tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease von Rutgeerts, Paul, D'Haens, Geert, Targan, Stephan, Vasiliauskas, Eric, Hanauer, Stephen B., Present, Daniel H., Mayer, Lloyd, Van Hogezand, Ruud A., Braakman, Tanja, DeWoody, Kimberly L., Schaible, Thomas F., Van Deventer, Sander J.H.

Volltext

Association of antibody responses to microbial antigens and complications of small bowel Crohn’s disease von Mow, William S., Vasiliauskas, Eric A., Lin, Ying-Chao, Fleshner, Phillip R., Papadakis, Konstantinos A., Taylor, Kent D., Landers, Carol J., Abreu-Martin, Maria T., Rotter, Jerome I., Yang, Huiying, Targan, Stephan R.

Volltext

Anti–tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behçet's disease: A case report von Hassard, Philip V., Binder, Scott W., Nelson, Viera, Vasiliauskas, Eric A.

Volltext

Infliximab in the treatment of medically refractory indeterminate colitis von Papadakis, K. A., Treyzon, L., Abreu, M. T., Fleshner, P. R., Targan, S. R., Vasiliauskas, E. A.

Volltext

Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup von Vasiliauskas, EA, Plevy, SE, Landers, CJ, Binder, SW, Ferguson, DM, Yang, H, Rotter, JI, Vidrich, A, Targan, SR

Volltext

Linkage of Crohn’s disease-related serological phenotypes: NFKB1 haplotypes are associated with anti-CBir1 and ASCA, and show reduced NF-κB activation von Takedatsu, H, Taylor, K D, Mei, L, McGovern, D P B, Landers, C J, Gonsky, R, Cong, Y, Vasiliauskas, E A, Ippoliti, A, Elson, C O, Rotter, J I, Targan, S R

Volltext

An open‐label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6‐mercaptopurine therapy von Dubinsky, Marla C., Hassard, Philip V., Seidman, Ernest G., Kam, Lori Y., Abreu, Maria T., Targan, Stephan R., Vasiliauskas, Eric A.

Volltext

A pilot study of adalimumab in infliximab‐allergic patients von Youdim, Adrienne, Vasiliauskas, Eric A., Targan, Stephan R., Papadakis, Konstantinos A., Ippoliti, Andrew, Dubinsky, Marla C., Lechago, Juan, Paavola, Jane, Loane, Jaime, Lee, Susie K., Gaiennie, Joanne, Smith, Katie, Do, Jason, Abreu, Maria T.

Volltext

The spectrum of gastrointestinal toxicity and effect on disease activity of selective cyclooxygenase‐2 inhibitors in patients with inflammatory bowel disease von Matuk, Robin, Crawford, Jonathan, Abreu, Maria T., Targan, Stephan R., Vasiliauskas, Eric A., Papadakis, Konstantinos A.

Volltext

Increased Immune Reactivity Predicts Aggressive Complicating Crohn's Disease in Children von Dubinsky, Marla C, Kugathasan, Subra, Mei, Ling, Picornell, Yoana, Nebel, Justin, Wrobel, Iwona, Quiros, Antonio, Silber, Gary, Wahbeh, Ghassan, Katzir, Lirona, Vasiliauskas, Eric, Bahar, Ron, Otley, Anthony, Mack, David, Evans, Jonathan, Rosh, Joel, Hemker, Maria Oliva, Leleiko, Neal, Crandall, Wallace, Langton, Christine, Landers, Carol, Taylor, Kent D, Targan, Stephan R, Rotter, Jerome I, Markowitz, James, Hyams, Jeffrey

Volltext

Immortal Beloved von Vasiliauskas, Emily

Volltext

Crohn’s ileitis after liver transplantation from a living related donor with Crohn’s disease von Papadakis, K A, Matuk, R, Abreu, M T, Vasiliauskas, E A, Fleshner, P R, Lechago, J, Tran, T, Poordad, F F, Martin, P, Vierling, J, Targan, S R

Volltext